$23.37
▲ +$0.64
(+2.82%)
Vol 1.4M
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$1.0B
ROE
-75.5%
D/E
0.00
Beta
-3.29
52W
$3–$12
Wall Street Consensus
17 analysts · Apr 20268
Strong Buy
8
Buy
1
Hold
0
Sell
0
Strong Sell
94.1%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 40.0%
Next Report
May 12, 2026
EPS Estimate: $-0.79
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.79 | — | — |
| Dec 2025 | $-1.00 | $-0.94 | +$0.06 |
| Sep 2025 | $-0.93 | $-1.06 | $-0.13 |
| Jun 2025 | $-1.41 | $-1.68 | $-0.27 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | — | — | $17.4M | $2.7M | $2.1M |
| Net Income | -$93.1M | -$94.8M | -$99.0M | $59.3M | -$110.8M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -72.1% | -140.5% | -72.1% | -72.1% | -72.1% | -75.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | 2225.1% | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 6.05 | 3.73 | 6.05 | 6.05 | 6.05 | 6.01 |
Key Ratios
ROA (TTM)
-57.6%
P/B
1.6
EPS (TTM)
$-3.85
52W High
$12.44
52W Low
$2.76
$2.76
52-Week Range
$12.44
Financial Health
Free Cash Flow
-$110.9M
Net Debt
-$27.5M
Cash
$65.3M
Total Debt
$37.8M
As of Sep 30, 2025
How does ALMS compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
ALMS valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
1.6
▼
22%
below
peers
(2.1)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
ALMS profitability vs Pharmaceuticals peers
ROE
-75.5%
▼
39%
below
peers
(-54.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
In line
ROA
-57.6%
▼
54%
below
peers
(-37.4%)
vs Peers
vs Industry
Below avg
ALMS financial health vs Pharmaceuticals peers
D/E ratio
0.0
▼
100%
below
peers
(1.5)
vs Peers
vs Industry
Low debt
Current ratio
6.0
▲
79%
above
peers
(3.4)
vs Peers
vs Industry
Below avg
Beta
-3.3
▼
450%
below
peers
(0.9)
vs Peers
vs Industry
More volatile
ALMS fundamentals radar
ALMS
Peer median
Industry
ALMS profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ALMS vs peers: key metrics
Latest News
No related news yet